Feb 14 (Reuters) - Novavax Inc (NVAX.O) said on Monday it had received interim authorization from the Singapore Health Sciences Authority (HSA) for its COVID-19 vaccine in adults. Register now for FREE unlimited access to Reuters.com. Register.
from Google Alert - health https://ift.tt/PJezsBo
via IFTTT
0 comments:
Post a Comment